IoPP: pharma packaging becomes strategic

Pharmaceutical packaging is no longer just the bottle, blister or carton around a drug; it is now part of the system that identifies and traces each saleable pack. (fda.gov) (multibriefs.com) The Institute of Packaging Professionals said in its April 27 update that packaging is becoming a “strategic differentiator” as biologics and personalized medicines add complexity to materials, labeling and production. (multibriefs.com) In plain terms, the package now carries identity data as well as product protection. The Food and Drug Administration says the Drug Supply Chain Security Act is meant to identify and trace certain prescription drugs at the package level through an interoperable electronic system. (fda.gov) That requirement reaches down to the printed code on the pack. FDA guidance says the product identifier includes the National Drug Code, serial number, lot number and expiration date, shown in human-readable text and in a machine-readable 2D data carrier. (fda.gov) Once those codes exist, companies need a common language to exchange the events tied to them. GS1 says its Electronic Product Code Information Services, or EPCIS, standard captures the what, when, where, why and how of product movement and chain of custody. (gs1.org) That is where packaging suppliers move closer to regulated operations. GS1 US says its DSCSA implementation suite is being rolled out in phases, with Release 1.3 timing set for dispensers in the third quarter of 2026, wholesalers in the fourth quarter of 2026 and manufacturers in the first quarter of 2027. (gs1us.org) Materials are part of the same shift. An IoPP packaging material data sheet for pharmaceutical use lists ultraviolet-light absorption, oxygen permeation, water-vapor transmission, sterilization methods and shelf-life data, showing the level of documentation buyers can ask converters to supply. (iopp.org) The pressure is higher for temperature-sensitive drugs. United States Pharmacopeia guidance says storage and transportation of finished drug products, including vaccines and biologics, are critical supply-chain activities involving many organizations worldwide. (usp.org) IoPP’s own pharmaceutical committee frames its role around the technical advances and problems of drug packaging, which now include materials compatibility, serialized coding and data-sharing standards rather than package protection alone. (iopp.org) (multibriefs.com) The result is a broader brief for label printers, carton makers and converters: document the substrate, print the code, and support the data trail that follows the medicine after it leaves the line. (fda.gov) (gs1us.org)